Journal of Autoimmunity (1996) 9, 415–421
IDDM2-VNTR-encoded Susceptibility to Type 1 Diabetes:
Dominant Protection and Parental Transmission of
Alleles of the Insulin Gene-linked Minisatellite Locus
Simon T. Bennett
1
, Amanda J. Wilson
1
, Francesco Cucca
1
, Jørn Nerup
2
,
Flemming Pociot
2
, Patricia A. McKinney
3
, Anthony H. Barnett
4
, Stephen C. Bain
4
, and
John A. Todd
1
1
The Wellcome Trust Centre for Human
Genetics, Nuffield Department of
Surgery, University of Oxford, Windmill
Road, Oxford OX3 7BN
2
Steno Diabetes Center, DK-2820
Gentofte, Denmark
3
Paediatric Epidemiology Group,
Research School of Medicine, University
of Leeds, Leeds LS2 9LN
4
Department of
Medicine/Diabetes/Endocrinology,
University of Birmingham, Birmingham
Heartlands Hospital, Bordesley Green
East, Birmingham B9 5SS
IDDM2-encoded predisposition to type 1 diabetes has recently been mapped
to the minisatellite or variable number of tandem repeat (VNTR) locus
upstream of the insulin and insulin-like growth factor II genes on human
chromosome 11p15.5. In a UK case-control study (n =228 sporadic diabetics;
n =441 healthy controls), we show here that the genotype homozygous for
VNTR class I alleles is predisposing to disease (RR=2.68), and VNTR class III
alleles are dominantly protective (RR=0.37). In 722 diabetic families from the
UK (n =356), USA (n =173), Denmark (n =55) and Sardinia (n =138), we have
analysed the transmission of class I alleles to diabetic offspring from class I/III
heterozygous parents. We confirm that in families from the USA, class I alleles
are transmitted preferentially from fathers. However, in family data sets from
the UK, Denmark and Sardinia, the reverse is true and maternal transmission
is stronger. Furthermore, in the UK family data set, the difference between
maternal and paternal transmissions is significant (P<0.05). It is therefore
unlikely that ‘maternal imprinting’ alone explains the parent-of-origin effects
in IDDM2-encoded predisposition to type 1 diabetes, at least not in the UK.
There is a relationship between VNTR class (allele length) and insulin gene
expression, though some results from different studies are conflicting. In the
human adult cadaveric pancreas, we confirm our preliminary results that class
III alleles are associated with lower levels of insulin mRNA in vivo. Similar
results have been obtained independently in human foetal pancreas samples.
It is difficult to explain how these marginally lower levels of insulin expression
could account for the observed VNTR class III-encoded protective effect.
Perhaps the site of action of IDDM2, mediated by VNTR allelic variation, is not
the pancreas but some other organ such as the thymus.
© 1996 Academic Press Limited
Key words: insulin gene
expression, genomic imprinting,
IDDM2
Introduction
Type 1, or insulin dependent diabetes mellitus
(IDDM), is one of the most common chronic diseases
in children with an incidence ranging from about 5 to
35 per 100,000 caucasoids of European descent [2].
Characterized by the autoimmune destruction of the
insulin-producing, pancreatic -cells of the islets of
Langerhans, type 1 diabetes pathogenesis is multifac-
torial, determined by both genetic and environmental
agents. Unravelling the genetic component by identi-
fying the predisposing aetiological mutations is an
essential step for a comprehensive approach to pre-
ventive therapy. A comparison of the risk to siblings of
type 1 diabetic subjects (6%) with the population risk
(0.4%), shows that there is appreciable clustering of
type 1 diabetes in families (
s
, or risk ratio=6/0.4=15;
Ref. 3). A large proportion of the genetic component of
this familial clustering is encoded for by genes
(IDDM1) in the immune response HLA region on
chromosome 6p21 [4–6], with smaller contributions
from as many as ten other loci outside the HLA region
[4, 7–12]. For example, in UK families, other than
IDDM1, eight putative non-HLA-encoded chromo-
some regions have now been mapped [12]. Assuming
a multiplicative model of inheritance, in which loci
interact epistatically, familial clustering of the disease
can be explained almost entirely by susceptibility
genes. Moreover, while the non-HLA-encoded suscep-
tibility loci each account for only a small proportion of
the familial clustering, the combined contribution of
Correspondence to: Dr Simon Bennett;
email: simon.bennett@well.ox.ac.uk
415
0896-8411/96/030415+07 $18.00/0 © 1996 Academic Press Limited